Page last updated: 2024-09-05

antiflammin p1 and hydroxyproline

antiflammin p1 has been researched along with hydroxyproline in 1 studies

Compound Research Comparison

Studies (antiflammin p1)	Trials (antiflammin p1)	Recent Studies (post-2010) (antiflammin p1)	Studies (hydroxyproline)	Trials (hydroxyproline)	Recent Studies (post-2010) (hydroxyproline)
23	0	3	10,942	334	1,426

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Cheng, QM; Feng, DD; Han, JZ; Huang, YH; Li, C; Li, Y; Liu, W; Luo, ZQ; Wan, J; Yue, SJ	1

Other Studies

1 other study(ies) available for antiflammin p1 and hydroxyproline

Article	Year
Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice. Respiratory research, 2013, Oct-08, Volume: 14 Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Cell Proliferation; Disease Models, Animal; Fibroblasts; Hydroxyproline; In Vitro Techniques; Interleukin-1beta; Lung; Male; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Peptide Fragments; Pulmonary Fibrosis; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha; Uteroglobin	2013

Article

Year

Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.

Respiratory research, 2013, Oct-08, Volume: 14

Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Cell Proliferation; Disease Models, Animal; Fibroblasts; Hydroxyproline; In Vitro Techniques; Interleukin-1beta; Lung; Male; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Peptide Fragments; Pulmonary Fibrosis; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha; Uteroglobin

2013